In which a vaccine for autism is posited:
A first-ever vaccine created by University of Guelph researchers for gut
bacteria common in autistic children may also help control some autism
symptoms. The groundbreaking study by Brittany Pequegnat and Guelph chemistry professor Mario Monteiro appears this month in the journal Vaccine.
They developed a carbohydrate-based vaccine against the gut bug Clostridium bolteae. C. bolteae is known to play a role in gastrointestinal disorders, and it often shows up in higher numbers in the GI tracts of autistic children than in those of healthy kids.
More than 90 per cent of children with autism spectrum disorders suffer from chronic, severe gastrointestinal symptoms. Of those, about 75 per cent suffer from diarrhea, according to current literature.
Thus raising the obvious question, how does C. bolteae manage to inordinately get itself into the intestinal tracts of autistic children? It’s customary, at this point, to ritually denounce Andrew Wakefield and Jenny McCarthy. But ask yourself this question: if as much as 50 percent of the studies published in academic science are, to put it kindly, flawed, what are the chances that the oft-cited surveys funded by the vaccine manufacturers, (who, you will recall, are one of the very few industries that are not legally responsible for their products), are not?
To reiterate, I am not a “vaccine denier”. Based on past discussions, I appear to understand the science and financial issues involved considerably better than most vaccine enthusiasts, including some medical doctors. I even got a tetanus vaccination myself only a few years ago. However, to understand that some vaccines are appropriate in some situations is very different than blithely assuming that all vaccinations are safe and appropriate in all circumstances.
It certainly fits with the break it and charge to fix it model that is presently so popular in the big business of modern medicine.